ATE507239T1 - Erhöhte sekretion/retention von wachstumshormonfreisetzendem hormon (ghrh) aus muskelzellen durch speziesspezifisches signalpeptid - Google Patents

Erhöhte sekretion/retention von wachstumshormonfreisetzendem hormon (ghrh) aus muskelzellen durch speziesspezifisches signalpeptid

Info

Publication number
ATE507239T1
ATE507239T1 AT05705515T AT05705515T ATE507239T1 AT E507239 T1 ATE507239 T1 AT E507239T1 AT 05705515 T AT05705515 T AT 05705515T AT 05705515 T AT05705515 T AT 05705515T AT E507239 T1 ATE507239 T1 AT E507239T1
Authority
AT
Austria
Prior art keywords
ghrh
species
retention
muscle cells
specific signaling
Prior art date
Application number
AT05705515T
Other languages
English (en)
Inventor
Ruxandra Draghia-Akli
Melissa Pope
Original Assignee
VGX Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VGX Pharmaceuticals LLC filed Critical VGX Pharmaceuticals LLC
Application granted granted Critical
Publication of ATE507239T1 publication Critical patent/ATE507239T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth-hormone releasing factors (GH-RF) (Somatoliberin)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT05705515T 2004-01-20 2005-01-13 Erhöhte sekretion/retention von wachstumshormonfreisetzendem hormon (ghrh) aus muskelzellen durch speziesspezifisches signalpeptid ATE507239T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53758204P 2004-01-20 2004-01-20
PCT/US2005/000892 WO2005073371A2 (en) 2004-01-20 2005-01-13 Enhanced secretion/retention of growth hormone releasing hormone (ghrh) from muscle cells by species-specific signal peptide

Publications (1)

Publication Number Publication Date
ATE507239T1 true ATE507239T1 (de) 2011-05-15

Family

ID=34825931

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05705515T ATE507239T1 (de) 2004-01-20 2005-01-13 Erhöhte sekretion/retention von wachstumshormonfreisetzendem hormon (ghrh) aus muskelzellen durch speziesspezifisches signalpeptid

Country Status (6)

Country Link
US (1) US7517863B2 (de)
EP (1) EP1713828B1 (de)
AT (1) ATE507239T1 (de)
CA (1) CA2595619A1 (de)
DE (1) DE602005027661D1 (de)
WO (1) WO2005073371A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7846720B2 (en) * 2005-01-26 2010-12-07 Vgx Pharmaceuticals, Inc. Optimized high yield synthetic plasmids
US8962818B2 (en) * 2008-03-06 2015-02-24 Vgx Pharmaceuticals, Inc. Compositions comprising GHRH and GnRH and methods of using the same
US8993316B2 (en) 2011-11-16 2015-03-31 Brian P. Hanley Methods and compositions for gene therapy and GHRH therapy

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224316A (en) 1979-03-30 1980-09-23 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4228156A (en) 1979-03-30 1980-10-14 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223021A (en) 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223020A (en) 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4228158A (en) 1979-03-30 1980-10-14 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4226857A (en) 1979-03-30 1980-10-07 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223019A (en) 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4410512A (en) 1981-12-28 1983-10-18 Beckman Instruments, Inc. Combinations having synergistic pituitary growth hormone releasing activity
ZA844380B (en) * 1983-07-05 1985-01-30 Salk Inst For Biological Studi Dna encoding a grf precursor
US5134120A (en) 1984-08-03 1992-07-28 Cornell Research Foundation, Inc. Use of growth hormone to enhance porcine weight gain
US5036045A (en) 1985-09-12 1991-07-30 The University Of Virginia Alumni Patents Foundation Method for increasing growth hormone secretion
US4833166A (en) 1987-05-01 1989-05-23 Grosvenor Clark E Growth hormone releasing hormone complementary peptides
US4839344A (en) 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
USRE33699E (en) 1987-07-09 1991-09-24 International Minerals & Chemical Corp. Growth hormone-releasing factor analogs
FR2622455B1 (fr) 1987-11-04 1991-07-12 Agronomique Inst Nat Rech Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes
US5023322A (en) 1988-08-31 1991-06-11 Mta Kutatas-Es Szervezetelemzo Intezete Analogs of growth hormone releasing factor (GRF) and a method for the preparation thereof
US5084442A (en) 1988-09-06 1992-01-28 Hoffmann-La Roche Inc. Cyclic growth hormone releasing factor analogs and method for the manufacture thereof
US5134210A (en) 1989-07-27 1992-07-28 Edwards Bill R Acrylic resin composition
US5137872A (en) 1989-09-18 1992-08-11 Pitman-Moore, Inc. Growth hormone-releasing factor analogs
ZA914983B (en) 1990-06-29 1992-03-25 Hoffmann La Roche His-grf-analogs
US5486505A (en) 1990-07-24 1996-01-23 Polygen Holding Corporation Polypeptide compounds having growth hormone releasing activity
JPH05507939A (ja) 1991-04-09 1993-11-11 エフ・ホフマン―ラ　ロシユ　アーゲー 成長ホルモン放出因子の類似体
US5663146A (en) 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
US5298422A (en) 1991-11-06 1994-03-29 Baylor College Of Medicine Myogenic vector systems
US5545130A (en) 1992-04-08 1996-08-13 Genetronics, Inc. Flow through electroporation method
US6132419A (en) 1992-05-22 2000-10-17 Genetronics, Inc. Electroporetic gene and drug therapy
US5507724A (en) 1992-07-01 1996-04-16 Genetronics, Inc. Electroporation and iontophoresis apparatus and method for insertion of drugs and genes into cells
US5439440A (en) 1993-04-01 1995-08-08 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US5702359A (en) 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
US5792747A (en) 1995-01-24 1998-08-11 The Administrators Of The Tulane Educational Fund Highly potent agonists of growth hormone releasing hormone
AU5441096A (en) 1995-04-14 1996-10-30 The Administrators Of The Tulane Eductional Fund Analogs of growth hormone-releasing factor
WO1997007826A1 (en) 1995-08-29 1997-03-06 Cbr Laboratories, Inc. In vivo electroporation of cells
EP1260229A3 (de) * 2001-05-18 2002-12-11 Sumitomo Pharmaceuticals Company, Limited Anti-Autoimmunpräparat das Inhibitoren der Aktivität von Wachstumshormon freisetzenden-Faktor enthält
WO2002097099A1 (en) * 2001-05-29 2002-12-05 Valentis, Inc. Regulated expression of ghrh
WO2003038112A2 (en) * 2001-10-26 2003-05-08 Baylor College Of Medicine A composition and method to alter lean body mass and bone properties in a subject
US20040204358A1 (en) * 2003-01-28 2004-10-14 Advisys, Inc. Reducing culling in herd animals growth hormone releasing hormone (GHRH)
EP1711187B1 (de) * 2003-12-31 2010-05-12 VGX Pharmaceuticals, LLC Reduzierung von arthritis und lahmheit bei personen unter supllement von wachstumshormon freisetzendem hormon (ghrh)

Also Published As

Publication number Publication date
US20050171046A1 (en) 2005-08-04
DE602005027661D1 (de) 2011-06-09
WO2005073371A2 (en) 2005-08-11
US7517863B2 (en) 2009-04-14
WO2005073371A3 (en) 2005-10-27
CA2595619A1 (en) 2005-08-11
EP1713828A2 (de) 2006-10-25
EP1713828B1 (de) 2011-04-27

Similar Documents

Publication Publication Date Title
Russo O verview of N europeptides: A wakening the S enses?
Harno et al. POMC: the physiological power of hormone processing
Yates-Binder et al. An IP-10 (CXCL10)-derived peptide inhibits angiogenesis
Gorissen et al. The endocrinology of the stress response in fish: an adaptation-physiological view
EA200800680A1 (ru) Пептидные ингибиторы пути трансдукции сигнала jnk, обладающие способностью проникать в клетку
Burbach What are neuropeptides?
Sen Dispersal of African mammals in Eurasia during the Cenozoic: ways and whys
Cuenca-Bescós et al. The small mammals of Sima del Elefante (Atapuerca, Spain) and the first entrance of Homo in Western Europe
Bover et al. Three islands, three worlds: paleogeography and evolution of the vertebrate fauna from the Balearic Islands
CY1114893T1 (el) Παραγωγη ανθρωπινης γλυκοσερεμπροσιδασης υψηλης μαννοζης σε φυτικη καλλιεργεια
HRP20192089T1 (hr) Metoda proizvodnje rekombinanta visoke molekularne težine vwf u staničnoj kulturi
ATE507239T1 (de) Erhöhte sekretion/retention von wachstumshormonfreisetzendem hormon (ghrh) aus muskelzellen durch speziesspezifisches signalpeptid
Becskei et al. Inhibitory effects of lipopolysaccharide on hypothalamic nuclei implicated in the control of food intake
DE602005010246D1 (de) Oligopeptide zur verringerung erhöhter blutharnstoffkonzentration
DE602005026157D1 (de) Von cdr2 oder cdr3 von trem-1 abgeleitete sequenzen enthaltende therapeutische peptide und deren anwendungen zur inhibierung von sepsis
EA201070623A1 (ru) Конструкция из полипептидов однодоменных антител, применение композиции, ее содержащей, и способ лечения ревматоидного артрита
UA115964C2 (uk) Інтерлейкін-13-зв'язувальний білок
IL168646A (en) Antibodies binding to human magic roundabout (mr) and uses thereof for inhibition of angiogenesis
Palombo Discrete dispersal bioevents of large mammals in Southern Europe in the post-Olduvai Early Pleistocene: A critical overview
Schwarz et al. Invasive Mantodea species in Europe
Saneyasu et al. Alpha-melanocyte stimulating hormone plays an important role in the regulation of food intake by the central melanocortin system in chicks
AR020315A1 (es) Un complejo de interferon tipo i(ifn) y una subunidad del receptor del interferon humano-(ifnar) que es capaz de unirse al inf tipo i del complejo, una molecula de adn, un vector, una celula huesped incapaz de conducir a la regeneracion de un animal o una planta transformada con un vector, una compo
ATE538806T1 (de) Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
Chen et al. Suckling-induced activation of neuronal input to the dorsomedial nucleus of the hypothalamus: possible candidates for mediating the activation of DMH neuropeptide Y neurons during lactation
Tovote et al. Curbing fear by axonal oxytocin release in the amygdala

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties